Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA: Lidocaine Ear Drops for Acute Otitis Media in Children
NCT05651633Phase 3Terminated
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in acute otitis media (AOM). Started Oct 2021; status: terminated.
02
Drugs
lidocaine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT05651633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05651633.